SCRA Technology Ventures Announces SBIR Match

Leukogene Therapeutics to Receive Funding to Improve Oncology Drug

CHARLESTON, S.C.--()--SCRA Technology Ventures today announced that Leukogene Therapeutics, Inc. (LTI) will receive a Phase I SBIR Match from its SC Launch program. LTI, a Charleston-based company, was newly accepted into the SC Launch program this month.

LTI is an oncology drug discovery and development company focused on the next generation of treatments for patients with incurable blood cancers like Multiple Myeloma. LTI was founded by Dr. Nathan Dolloff, who was recently recruited by the Medical University of South Carolina’s Department of Cell and Molecular Pharmacology. The company is working to optimize the chemical structure of its lead-stage compound that has exhibited promising preclinical activity against Multiple Myeloma and Non-Hodgkin’s Lymphomas.

“LTI is working to discover and develop therapeutics for cancers that, to-date, have been incurable,” said SCRA CEO Bill Mahoney. “We are delighted to support the efforts of this South Carolina company as it brings hope and progress to the fight against cancer.”

ABOUT SCRA TECHNOLOGY VENTURES

http://www.scra.org/

SCRA Technology Ventures helps innovative companies grow and develop new technologies, creating jobs and advancing the Knowledge Economy throughout South Carolina. This SCRA business sector provides support and mentoring to early stage, start-up technology companies through its flagship SC Launch program. Since 2006, SCRA has deployed over $82 million in funding for entrepreneurs and infrastructure to support over 290 high-tech, early-stage enterprises. SCRA has directly invested over $19 million into the program’s top 71 South Carolina start-ups, attracting over $301 million in add-on, private investment. The sector also supports commercialization and growth by facilitating the transfer of intellectual property and accelerating the transition of inventions to the marketplace.

Multiple economic impact studies show SCRA's cumulative output on South Carolina's economy to be over $16.6 billion, and that the company has helped create approximately 15,000 technology-related jobs in the state, with annual wages averaging between $55,000 and $77,000.

Contacts

SCRA
Micki Howard MacNaughton
843-760-3329 office
843-697-9226 mobile
micki.howard@scra.org

Release Summary

SCRA Technology Ventures matches SBIR for Charleston, SC-based oncology company Leukogene Therapeutics, Inc.

Contacts

SCRA
Micki Howard MacNaughton
843-760-3329 office
843-697-9226 mobile
micki.howard@scra.org